Associations between CD4 cell counts and clinical presentations among HIV/AIDS patients in Cameroon

Journal of Medical Sciences

Volumn 6, Issue 5, 2006, Pages 843-847

  Alemnji, G ^a   Mbuagbaw, J ^a,b   Afetane, G ^a   Nkam, M ^a,b  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^b University Teaching Hospital Yaounde   (Cameroon)

Author keywords

Cameroon; CD4 cells; HIV AIDS

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANEMIA; ARTICLE; AWARENESS; CAMEROON; CD4+ T LYMPHOCYTE; CLINICAL FEATURE; CONTROLLED STUDY; COUGHING; COUNSELING; DEMOGRAPHY; DIARRHEA; FATIGUE; FEMALE; FEVER; GENITAL HERPES; HERPES ZOSTER; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMED CONSENT; KAPOSI SARCOMA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MENINGITIS; PATIENT EDUCATION; PNEUMONIA; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; THRUSH; TUBERCULOSIS; WEIGHT REDUCTION;

EID: 33845244101     PISSN: 16824474     EISSN: 18125727     Source Type: Journal    
DOI: 10.3923/jms.2006.843.847     Document Type: Article

References (33)

1. Alemnji, G.A., 2002. HIV Seroprevalence among people reporting in various hospitals in Cameroon. Proceedings of a seminar on prevention of Mother to child transmission of HIV, Bamenda, Cameroon, 17-19th June, pp: 15-16.
2. Anonymous, 2004. Rapid HIV tests: guidelines for use in HIV testing and counselling services in resources-constrained settings. World Health Organisation, Geneva, Switzerland.
3. Ansari, N.A., A.H. Kombe, T.A. Kenyon, N.M. Hone, J.W. Tappero and S.T. Nyerinda et al., 2002. Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997-1998. Intl. J. Turb. Lun. D., 2: 55-63.
4. Barklett J. and J. Gallant, 2003. Medical management of HIV infection: John Hopkins University School of medicine, Ed 2003, Baltimore, Maryland (United States of America).
5. Behler, C., S. Shade, K. Gregory, D. Abrams and P. Volberding, 2005. Anemia and HIV in the antiretroviral era potential significance of testosterone. AIDS. Res. Hum. Retroviruses. 21: 200-206.
6. Bimenyu, C. and C. Kuaban, 2001. Pulmonary tuberculosis in HIV infection: is chest radiographic appearance related to CD4+ T lymphocyte count in Yaoundé. (abstract) Health Sci. Dis., Vol: A401.
7. CDC, 1993. Revised classification system for HIV infection and expanded surveillance definition for AIDS among adolescents and adults. MWWR., 1992, 41: 1-191.
8. Coetzee, D., K. Hildebrand, A. Boulle, C. Maarteens F. Louis and V. Labatala et al., 2004. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS, 18: 887-895.
9. Gaydos, C.A., 2006. Rapid Tests for Sexually Transmitted Diseases. Curr. Infect. Dis. Rep., 8: 115-124.
10. Goujard, C.B., M. Bonarek, L. Meyer, F. Bonne and M.L. Chaix et al., 2006. Agence National de Recherche sur le Sida PRIMO Study Group. CD4 cell counts and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients. Clin. Infect. Dis., 42: 709-714.
11. Granade, T.C., B.S. Parekh, P.M. Tih, T. Welty, E. Welty et al., 2005. Evaluation of rapid prenatal human immunodeficiency virus testing in rural cameroon. Clini. diagnostic lab. Immunol., 12: 855-860.
12. HAART-associated adverse clinical events, 2002. In: Guidelines for use of antiretroviral agents in HIV-Infected adults and adolescents. Department of Health and Human Services, USA 2002, pp: 5-6.
13. Jaffar, S., A.D. Grant, J. Whitworth, P.G. Smith and H. Whittle, 2004. The Natural history of HIV-1 infection in adults in Africa: A literature review. Bull. WHO., 82: 462-467.
14. Jaffar, S., M.S. Loeff, J. Eugen-Olsen, T. Vincent and R. Sarje-Njie et al., 2005. Immunological predictors of survival in HIV type 2-infected rural villages in Guinea-Bissau. AIDS Res. Hum. Retroviruses, 21: 560-564.
15. Lawn, S.D., L. Myer, C. Orrel, L.G. Bekker and R. Wood, 2005. Early mortality among adults accessing a community-based antiretroviral service in South Africa: Implications for programme designed. AIDS; 19: 2141-2148.
16. Letvin, N.L. and B.D. Walker, 2003, Immunopathogenesis and immunotherapy in AIDS virus infection. Nature Med., 9: 861-866.
17. Lucas, S.B., A. Hounnou, C. Peacock, A. Beaumel G. Djomand and J.M. N'Cbichi et al., 1993. The mortality and pathology of HIV infection in a West African city. AIDS; 7: 1567-1579.
18. Mbuagbaw, J., I. Eyong, G. Alemnji, N. Mpoudi Same and S. Ekobo, 2006. Patterns of skin manifestations and their relationship with CD4 counts among HIV/AIDS patients in Cameroon. Intl. J. Dermatol., 45: 280-284.
19. McMichael, A.J. and J. Hanke, 2003. HIV vaccines 1983-2003. Nat. Mad., 9: 874-880.
20. Moyle, G., 2002. Anaemia in persons with HIV infection: Prognostic markers and contribution to morbidity. AIDS Rev., 4: 13-20.
21. Nacher, M., M. El Guedj, V. Vaz, V. Nasser, A. Randrianjohany, F. Alvarez, M. Sobesky, C. Magnien and P. Couppie, 2005. Risk factors for late HIV diagnosis in french Guiana AIDS, 19: 727-729.
22. National AIDS Control Committee: National Guidelines for the Prevention of HIV in Cameroon N° 15131; November 2002.
23. National AIDS Control Committee/National Statistic Institute: Preliminary Report of Cameroon Demographic and Health Survey, January 2004.
24. Nkengasong, J.N., C. Adje-Toure and P.J. Weidle, 2004. HIV antiretroviral drug resistance in Africa. AIDS Rev., 6: 4-12.
25. Perriens, J., 1999. Clinical aspects of HIV-related opportunistic diseases in Africa: Tuberculosis and candidiasis. Université de Gand.
26. Philips, A.N., Staszewski and R. Weber et al., 2001. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. JAMA., 286: 2560-2567.
27. UNAIDS: AIDS Epidemic Update. December 2005.
28. Van Leth, F., S. Andrews, B. Grinsztejn, F. Wilkins M.K. Lazanas, J.M. Lange, J. Montaner and 2NN study group, 2005. The effect of baseline CD4 cell counts and HIV-1 viral load on the efficacy and safety of nevirapine or efaviranz-based first-line HAART. AIDS, 19: 463-471.
29. Weidle, P.J., S. Malamba, R. Mwebaze, C. Sozi, C. Rukundo and R. Downing et al., 2002. Assessment of a pilot antiretroviral drug therapy program in Uganda patients' response, survival and drug resistance. Lancet, 360: 34-40.
30. WHO: Amelioration of access to antiretroviral treatment in resource limited countries: Recommendations for a public health approach, 2002.
31. World Health Organisation. Scaling up Antiretroviral Therapy in Resource-Limited Settings. Guidelines for a Public Health Approach. Executive Summary, Geneva: World Health Organisation 2002. Accessed 15 April 2005: http//www.who.int/hiv/pub/prevcare/en/WHO-ARV-Guidelines.pdf.
32. Wiwanitkit, V., 2004. Prevalence of dermatological disorders in Thai HIV-infected patients correlation with different CD4 lymphocyte count statuses. A note on 120 cases. Intl. J. Dermatol., 43: 265-268.
33. Yazdanpanah, Y., G. Chene and E. Losina et al., 2001. Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts. Intl. J. Epidemiol., 30: 864-871.